(Q30749943)

English

Multivariate regression analyses of data from a randomised, double-blind, placebo-controlled study confirm quality of life benefit of epoetin alfa in patients receiving non-platinum chemotherapy

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

15 August 2017

Multivariate regression analyses of data from a randomised, double-blind, placebo-controlled study confirm quality of life benefit of epoetin alfa in patients receiving non-platinum chemotherapy (English)

1 reference

Europe PubMed Central

15 August 2017

0 references

0 references

quality of life

1 reference

based on heuristic

inferred from title

multivariate statistics

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

Lesley Fallowfield

1

1 reference

Europe PubMed Central

26 June 2017

author name string

D Gagnon

2

1 reference

Europe PubMed Central

15 August 2017

M Zagari

3

1 reference

Europe PubMed Central

15 August 2017

D Cella

4

1 reference

Europe PubMed Central

15 August 2017

B Bresnahan

5

1 reference

Europe PubMed Central

15 August 2017

T J Littlewood

6

1 reference

Europe PubMed Central

15 August 2017

P McNulty

7

1 reference

Europe PubMed Central

15 August 2017

G Gorzegno

8

1 reference

Europe PubMed Central

15 August 2017

M Freund

9

1 reference

Europe PubMed Central

15 August 2017

Epoetin Alfa Study Group

10

1 reference

Europe PubMed Central

15 August 2017

language of work or name

0 references

publication date

1 December 2002

1 reference

Europe PubMed Central

15 August 2017

British Journal of Cancer

1 reference

Europe PubMed Central

15 August 2017

87

1 reference

Europe PubMed Central

15 August 2017

12

1 reference

Europe PubMed Central

15 August 2017

1341-1353

1 reference

Europe PubMed Central

15 August 2017

Human recombinant erythropoietin and quality of life: a wonder drug or something to wonder about?

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2376290

20 June 2018

Effects of epoetin alfa on the central nervous system

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2376290

20 June 2018

Effects of epoetin alfa on hematologic parameters and quality of life in cancer patients receiving nonplatinum chemotherapy: results of a randomized, double-blind, placebo-controlled trial.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2376290

20 June 2018

The CONSORT statement: revised recommendations for improving the quality of reports of parallel-group randomised trials

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2376290

20 June 2018

Erythropoietin crosses the blood-brain barrier to protect against experimental brain injury

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2376290

20 June 2018

Large-scale UK audit of blood transfusion requirements and anaemia in patients receiving cytotoxic chemotherapy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2376290

20 June 2018

Fatigue in cancer patients

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2376290

20 June 2018

Normalizing hematocrit in dialysis patients improves brain function

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2376290

20 June 2018

Translating health status questionnaires and evaluating their quality: the IQOLA Project approach. International Quality of Life Assessment.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2376290

20 June 2018

Factors influencing quality of life in cancer patients: anemia and fatigue.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2376290

20 June 2018

Missing quality of life data in cancer clinical trials: serious problems and challenges

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2376290

20 June 2018

Fatigue in cancer and HIV/AIDS.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2376290

20 June 2018

Impact of therapy with epoetin alfa on clinical outcomes in patients with nonmyeloid malignancies during cancer chemotherapy in community oncology practice. Procrit Study Group

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2376290

20 June 2018

Fatigue and the cancer experience: the state of the knowledge

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2376290

20 June 2018

rHuEPO treatment improves brain and cognitive function of anemic dialysis patients

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2376290

20 June 2018

Recombinant human erythropoietin in the treatment of the anaemia of cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2376290

20 June 2018

Cancer-related fatigue: prevalence of proposed diagnostic criteria in a United States sample of cancer survivors.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2376290

25 November 2018

Clinical evaluation of once-weekly dosing of epoetin alfa in chemotherapy patients: improvements in hemoglobin and quality of life are similar to three-times-weekly dosing.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2376290

25 November 2018

Impact of cancer-related fatigue on the lives of patients: new findings from the Fatigue Coalition.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2376290

25 November 2018

Cancer-related fatigue: inevitable, unimportant and untreatable? Results of a multi-centre patient survey. Cancer Fatigue Forum.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2376290

25 November 2018

Quality-of-life benefit in chemotherapy patients treated with epoetin alfa is independent of disease response or tumor type: results from a prospective community oncology study. Procrit Study Group.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2376290

25 November 2018

Patient, caregiver, and oncologist perceptions of cancer-related fatigue: results of a tripart assessment survey. The Fatigue Coalition

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2376290

25 November 2018

Quality of life in chronic anemia of cancer during treatment with recombinant human erythropoietin.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2376290

25 November 2018

The Functional Assessment of Cancer Therapy-Anemia (FACT-An) Scale: a new tool for the assessment of outcomes in cancer anemia and fatigue

1 reference

https://pubmed.ncbi.nlm.nih.gov/12454760

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The Schwartz Cancer Fatigue Scale: testing reliability and validity

1 reference

https://pubmed.ncbi.nlm.nih.gov/12454760

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Anemia in cancer patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/12454760

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Fatigue--an orphan topic in patients with cancer?

1 reference

https://pubmed.ncbi.nlm.nih.gov/12454760

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Predicting cancer-associated anaemia in patients receiving non-platinum chemotherapy: results of a retrospective survey

1 reference

https://pubmed.ncbi.nlm.nih.gov/12454760

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A sharper Bonferroni procedure for multiple tests of significance

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJC.6600657

7 January 2021

based on heuristic

inferred from DOI database lookup

Fatigue in patients with cancer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJC.6600657

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1038/SJ.BJC.6600657

1 reference

Europe PubMed Central

15 August 2017

Dimensions Publication ID

0 references

1 reference

Europe PubMed Central

15 August 2017

1 reference

Europe PubMed Central

15 August 2017

ResearchGate publication ID

0 references

Springer Nature article ID

10.1038/sj.bjc.6600657

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q30749943&oldid=2047550991"